miR-15b-5p REGULATES THE NLRP3 INFLAMMASOME SIGNAL THROUGH TARGETING SIRT3 TO REGULATE HYPOXIA/REOXYGENATION-INDUCED CARDIOMYOCYTE PYROPTOSIS PROCESS-Reference-Cited by-同舟云学术

miR-15b-5p REGULATES THE NLRP3 INFLAMMASOME SIGNAL THROUGH TARGETING SIRT3 TO REGULATE HYPOXIA/REOXYGENATION-INDUCED CARDIOMYOCYTE PYROPTOSIS PROCESS

Published:2022-07-24 Issue:2 Volume:58 Page:147-157
ISSN:1073-2322
Container-title:Shock
language:en
Short-container-title:Shock

Author:

Xu Jiawei,Chen Xuexia,Nie Wenhong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine,Emergency Medicine

Reference46 articles.

1. Acute myocardial infarction;N Engl J Med,2017

2. Lncrna rp11-400k9.4 aggravates cardiomyocytes apoptosis after hypoxia/reperfusion injury by targeting mir-423;Int Heart J,2021

3. Propofol protects h9c2 cells against hypoxia/reoxygenation injury through mir-449a and nr4a2;Exp Ther Med,2021

4. Mir-424 promotes cardiac ischemia/reperfusion injury by direct targeting of crispld2 and regulating cardiomyocyte pyroptosis;Int J Clin Exp Pathol,2018

5. Aesculin suppresses the nlrp3 inflammasome-mediated pyroptosis via the akt/gsk3β/nf-κb pathway to mitigate myocardial ischemia/reperfusion injury;Phytomedicine,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic regulation of diverse regulated cell death modalities in cardiovascular disease: Insights into necroptosis, pyroptosis, ferroptosis, and cuproptosis;Redox Biology;2024-10

2. MicroRNA-15b promotes cardiac ischemia injury by the inhibition of Mitofusin 2/PERK pathway;Biochemical Pharmacology;2024-08

3. Sirt3 Mediates the Cardioprotective Effect of Therapeutic Hypothermia after Cardiac Arrest and Resuscitation by Restoring Autophagic Flux via the PI3K/Akt/mTOR Pathway;Shock;2024-03-25

4. SIRT3 regulates mitochondrial function: A promising star target for cardiovascular disease therapy;Biomedicine & Pharmacotherapy;2024-01

5. MicroRNA Regulation for Inflammasomes in High Glucose‐Treated ARPE‐19 Cells;Journal of Ophthalmology;2024-01